Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 7, Issue 21
November 14 2023
Issue Cover

Table of Contents

INSIDE BLOOD ADVANCES

ICANS prophylaxis: potentially transformative but elusive
Clinical Trials & Observations
Mark R. Dowling,Cameron J. Turtle
View Articletitled, ICANS prophylaxis: potentially transformative but elusive

SYSTEMATIC REVIEWS

Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis
Hervé Lobbes,Jean-Christophe Lega,Guillaume Le Guenno,Marc Ruivard,Sabine Mainbourg
View Articletitled, Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis
Supplemental data

Comprehensive cancer treatment approach incorporating Social Determinants of Health. Created with BioRender.com.

Disparities in survival of hematologic malignancies in the context of social determinants of health: a systematic review
Marisol Miranda-Galvis,Kellen C. Tjioe,E. Andrew Balas,Gagan Agrawal,Jorge E. Cortes
View Articletitled, Disparities in survival of hematologic malignancies in the context of social determinants of health: a systematic review
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study
Clinical Trials & Observations
Adam S. Zayac,Daniel J. Landsburg,Mitchell E. Hughes,Allison M. Bock,Grzegorz S. Nowakowski,Emily C. Ayers,Mark Girton,Marie Hu,Amy K. Beckman,Shaoying Li,L. Jeffrey Medeiros,Julie E. Chang,Adam Stepanovic,Habibe Kurt,Jose Sandoval-Sus,M. Ali Ansari-Lari,Shalin K. Kothari,Anna Kress,Mina L. Xu,Pallawi Torka,Suchitra Sundaram,Stephen D. Smith,Kikkeri N. Naresh,Yasmin H. Karimi,Narendranath Epperla,David A. Bond,Umar Farooq,Mahak Saad,Andrew M. Evens,Karan Pandya,Seema G. Naik,Manali Kamdar,Bradley Haverkos,Reem Karmali,Timothy S. Oh,Julie M. Vose,Heather Nutsch,Paul G. Rubinstein,Amina Chaudhry,Adam J. Olszewski
View Articletitled, High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study
Supplemental data
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia
Clinical Trials & Observations
Farhad Ravandi,Asad Bashey,James Foran,Wendy Stock,Raya Mawad,Nicholas Short,Musa Yilmaz,Hagop Kantarjian,Olatoyosi Odenike,Anand Patel,Raman Garcha,William Barrett Ainsworth,Raphael Clynes,Jitendra Kanodia,Ying Ding,Huajiang Li,Steve Kye,Alice Mims
View Articletitled, Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia
Supplemental data
Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome
Clinical Trials & Observations
Nikhil Raghuram,Daisuke Hasegawa,Kentaro Nakashima,Syaza Rahman,Evangelia Antoniou,Torjus Skajaa,Pietro Merli,Anupam Verma,Karen R. Rabin,Catherine Aftandilian,Rishi S. Kotecha,Daniel Cheuk,Kirsi Jahnukainen,Alexandra Kolenova,Walentyna Balwierz,Alice Norton,Maureen O’Brien,Sonia Cellot,Ashley Chopek,Nira Arad-Cohen,Bianca Goemans,Marta Rojas-Vasquez,Hany Ariffin,Jack Bartram,E. Anders Kolb,Franco Locatelli,Jan-Henning Klusmann,Henrik Hasle,Bryan McGuire,Afia Hasnain,Lillian Sung,Johann Hitzler
View Articletitled, Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome
Supplemental data
Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma
Clinical Trials & Observations
Samuel Yamshon,Gui Zhen Chen,Caitlin Gribbin,Paul Christos,Bijal Shah,Stephen J. Schuster,Sonali M. Smith,Jakub Svoboda,Richard R. Furman,John P. Leonard,Peter Martin,Jia Ruan
View Articletitled, Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma
International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies
Clinical Trials & Observations
Belinda A. Campbell,Gabor Dobos,Zahra Haider,H. Miles Prince,Martine Bagot,Felicity Evison,Carrie van der Weyden,Chris McCormack,Caroline Ram-Wolff,Maryam Miladi,Julia J Scarisbrick
View Articletitled, International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies
Supplemental data
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes
Clinical Trials & Observations
Sheila K. Pierson,Megan S. Lim,Gordan Srkalovic,Joshua D. Brandstadter,Mateo Sarmiento Bustamante,Saishravan Shyamsundar,Natalie Mango,Criswell Lavery,Bridget Austin,Daisy Alapat,Mary Jo Lechowicz,Adam Bagg,Hongzhe Li,Corey Casper,Frits van Rhee,David C. Fajgenbaum
View Articletitled, Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes
Supplemental data
Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines
Clinical Trials & Observations
Thomas V. Adamkiewicz,Marianne E. M. Yee,Stepy Thomas,Amy Tunali,Kristina W. Lai,Folashade S. Omole,Peter A. Lane,Inci Yildirim
View Articletitled, Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines
Supplemental data
A phase 2 trial of defibrotide for the prevention of chimeric antigen receptor T-cell–associated neurotoxicity syndrome
Clinical Trials & Observations
Caron A. Jacobson,Allison C. Rosenthal,Jon Arnason,Shirali Agarwal,Peixin Zhang,Wendy Wu,Vian Amber,Jean A. Yared
View Articletitled, A phase 2 trial of defibrotide for the prevention of chimeric antigen receptor T-cell–associated neurotoxicity syndrome
Supplemental data
ICANS prophylaxis: potentially transformative but elusive
Clinical Trials & Observations
Mark R. Dowling,Cameron J. Turtle
View Articletitled, ICANS prophylaxis: potentially transformative but elusive

HEMATOPOIESIS AND STEM CELLS

Late fetal hematopoietic failure results from ZBTB11 deficiency despite abundant HSC specification
Huimin Cao,Shalin H. Naik,Daniela Amann-Zalcenstein,Peter Hickey,Agus Salim,Benjamin Cao,Susan K. Nilsson,M. Cristina Keightley,Graham J. Lieschke
View Articletitled, Late fetal hematopoietic failure results from ZBTB11 deficiency despite abundant HSC specification
Supplemental data
Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis
Vikas Madan,Pavithra Shyamsunder,Pushkar Dakle,Teoh Weoi Woon,Lin Han,Zeya Cao,Hazimah Binte Mohd Nordin,Shi Jizhong,Yu Shuizhou,Md Zakir Hossain,H. Phillip Koeffler
View Articletitled, Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis
Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies
Olivia Perez de Acha,Lauren Reiman,David S. Jayabalan,Zachary J. Walker,Grace Bosma,Alana L. Keller,Sarah E. Parzych,Diana Abbott,Beau M. Idler,Drew Ribadeneyra,Ruben Niesvizky,Peter A. Forsberg,Tomer M. Mark,Daniel W. Sherbenou
View Articletitled, CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies
Supplemental data
T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia
Chiara Montironi,Chaja F. Jacobs,Gaspard Cretenet,Fleur S. Peters,Bauke V. Schomakers,Michel van Weeghel,Arnon P. Kater,Helga Simon-Molas,Eric Eldering
View Articletitled, T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia
Supplemental data

LYMPHOID NEOPLASIA

MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis
Alexia Katsarou,Nikolaos Trasanidis,Kanagaraju Ponnusamy,Ioannis V. Kostopoulos,Jaime Alvarez-Benayas,Foteini Papaleonidopoulou,Keren Keren,Pierangela M. R. Sabbattini,Niklas Feldhahn,Maria Papaioannou,Evdoxia Hatjiharissi,Ian M. Sudbery,Aristeidis Chaidos,Valentina S. Caputo,Anastasios Karadimitris
View Articletitled, MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis
Supplemental data
Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry
Clinical Trials & Observations
Jean Lemoine,Emmanuel Bachy,Guillaume Cartron,David Beauvais,Thomas Gastinne,Roberta Di Blasi,Marie-Thérèse Rubio,Stéphanie Guidez,Mohamad Mohty,Rene-Olivier Casasnovas,Magalie Joris,Cristina Castilla-Llorente,Corinne Haioun,Olivier Hermine,Michael Loschi,Sylvain Carras,Pierre Bories,Tom Fradon,Charles Herbaux,Pierre Sesques,Steven Le Gouill,Franck Morschhauser,Catherine Thieblemont,Roch Houot
View Articletitled, Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry
Supplemental data
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort
Jackson T. Bowers,Jacob Anna,Steven M. Bair,Kaitlin Annunzio,Narendranath Epperla,Jerrin Joy Pullukkara,Sameh Gaballa,Michael A. Spinner,Shuning Li,Marcus R. Messmer,Joseph Nguyen,Emily C. Ayers,Charlotte B. Wagner,Boyu Hu,Mengyang Di,Scott F. Huntington,Fateeha Furqan,Nirav N. Shah,Christina Chen,Hatcher J. Ballard,Mitchell E. Hughes,Elise A. Chong,Sunita D. Nasta,Stefan K. Barta,Daniel J. Landsburg,Jakub Svoboda
View Articletitled, Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort
Supplemental data
DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia
Amy N. Sexauer,Gabriela Alexe,Karin Gustafsson,Elizabeth Zanetakos,Jelena Milosevic,Mary Ayres,Varsha Gandhi,Yana Pikman,Kimberly Stegmaier,David B. Sykes
View Articletitled, DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia
Supplemental data
Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
Julia Driessen,Gerben J. C. Zwezerijnen,Heiko Schöder,Marie José Kersten,Alison J. Moskowitz,Craig H. Moskowitz,Jakoba J. Eertink,Martijn W. Heymans,Ronald Boellaard,Josée M. Zijlstra
View Articletitled, Prognostic model using <sup>18</sup>F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
Supplemental data

MYELOID NEOPLASIA

Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial
Clinical Trials & Observations
Jorge Sierra,Pau Montesinos,Xavier Thomas,Laimonas Griskevicius,Thomas Cluzeau,Denis Caillot,Ollivier Legrand,Clara Minotti,Mario Luppi,Firas Farkas,Bourras-Rezki Bengoudifa,Geralyn Gilotti,Sejla Hodzic,Alessandro Rambaldi,Adriano Venditti
View Articletitled, Midostaurin plus daunorubicin or idarubicin for young and older adults with <em>FLT3</em>-mutated AML: a phase 3b trial
Supplemental data
AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technology
Marius-Konstantin Klever,Eric Sträng,Sara Hetzel,Julius Jungnitsch,Anna Dolnik,Robert Schöpflin,Jens-Florian Schrezenmeier,Felix Schick,Olga Blau,Jörg Westermann,Frank G. Rücker,Zuyao Xia,Konstanze Döhner,Hubert Schrezenmeier,Malte Spielmann,Alexander Meissner,Uirá Souto Melo,Stefan Mundlos,Lars Bullinger
View Articletitled, AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technology
Supplemental data
Long-term outcomes among adults with Langerhans cell histiocytosis
Gaurav Goyal,Aldo A. Acosta-Medina,Jithma P. Abeykoon,Chen Dai,Aishwarya Ravindran,Robert Vassallo,Jay H. Ryu,Mithun V. Shah,N. Nora Bennani,Jason R. Young,Corrie R. Bach,Gordon J. Ruan,Saurabh Zanwar,W. Oliver Tobin,Matthew J. Koster,Caroline J. Davidge-Pitts,Lucinda M. Gruber,Surendra Dasari,Karen L. Rech,Ronald S. Go,on behalf of the Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group
View Articletitled, Long-term outcomes among adults with Langerhans cell histiocytosis
Supplemental data
The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression
Youmna S. Kfoury,Fei Ji,Esha Jain,Michael Mazzola,Giulia Schiroli,Ani Papazian,Francois Mercier,David B. Sykes,Anna Kiem,Mark Randolph,Laura M. Calvi,Omar Abdel-Wahab,Ruslan I. Sadreyev,David T. Scadden
View Articletitled, The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression
Supplemental data

THROMBOSIS AND HEMOSTASIS

Crucial roles of red blood cells and platelets in whole blood thrombin generation
Siyu Sun,Elena Campello,Jinmi Zou,Joke Konings,Dana Huskens,Jun Wan,Delia I. Fernández,Chris P. M. Reutelingsperger,Hugo ten Cate,Serena Toffanin,Cristiana Bulato,Philip G. de Groot,Bas de Laat,Paolo Simioni,Johan W. M. Heemskerk,Mark Roest
View Articletitled, Crucial roles of red blood cells and platelets in whole blood thrombin generation
Supplemental data
von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model
Olga Oleshko,Nadine Vollack-Hesse,Andreas Tiede,Jan Hegermann,Ute Curth,Sonja Werwitzke
View Articletitled, von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model
Supplemental data

TRANSPLANTATION

Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
Clinical Trials & Observations
Wancheng Guo,Anne Zhan,David E. Mery,Manit N. Munshi,Oussama Makhoul,Clyde Baily,Maurizio Zangari,Guido Tricot,Hongling Peng,John D. Shaughnessy, Jr.
View Articletitled, Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
Supplemental data
Circulating microbial cell–free DNA is increased during neutropenia after hematopoietic stem cell transplantation
Lily M. Blair,Jamilla Akhund-Zade,Zoe A. Katsamakis,Olivia C. Smibert,Alex E. Wolfe,Paul Giardina,John Slingerland,Sivan Bercovici,Miguel-Angel Perales,Ying Taur,Marcel R. M. van den Brink,Jonathan U. Peled,Kate A. Markey
View Articletitled, Circulating microbial cell–free DNA is increased during neutropenia after hematopoietic stem cell transplantation
Supplemental data

VASCULAR BIOLOGY

Platelets regulate ischemia-induced revascularization and angiogenesis by secretion of growth factor–modulating factors
Henry Nording,Lasse Baron,Manuela Sauter,Antje Lübken,Elias Rawish,Rebecca Szepanowski,Jacob von Esebeck,Ying Sun,Hossein Emami,Moritz Meusel,Roza Saraei,Nancy Schanze,Sivahari Prasad Gorantla,Nikolas von Bubnoff,Tobias Geisler,Philipp von Hundelshausen,Konstantinos Stellos,Jens Marquardt,Christian D. Sadik,Jörg Köhl,Daniel Duerschmied,Christoph Kleinschnitz,Harald F. Langer
View Articletitled, Platelets regulate ischemia-induced revascularization and angiogenesis by secretion of growth factor–modulating factors
Supplemental data

RESEARCH LETTERS

Monoallelic deletion of BCMA is a frequent feature in multiple myeloma
Mehmet Kemal Samur,Anil Aktas Samur,Jill Corre,Romain Lannes,Parth Shah,Kenneth Anderson,Hervé Avet-Loiseau,Nikhil Munshi
View Articletitled, Monoallelic deletion of <em>BCMA</em> is a frequent feature in multiple myeloma
Supplemental data
Evaluating complement dysregulation in livedoid vasculopathy using a functional assay
Harish Eswaran,Shruti Chaturvedi,Robert A. Brodsky,Gloria F. Gerber,Xiang-Zuo Pan,Stephan Moll
View Articletitled, Evaluating complement dysregulation in livedoid vasculopathy using a functional assay
Cigarette smoke exposure accelerates AML progression in FLT3-ITD models
Clinical Trials & Observations
Mary Figueroa,Huaxian Ma,Mansour Alfayez,Daniel Enrique Morales-Mantilla,Fei Wang,Yue Lu,Marcos R. Estecio,Katherine Y. King,Eugenie Kleinerman,Seyed Javad Moghaddam,Naval Daver,Michael Andreeff,Marina Konopleva,Courtney DiNardo,Joya Chandra
View Articletitled, Cigarette smoke exposure accelerates AML progression in FLT3-ITD models
Supplemental data
FUTURES: efficacy and acceptability of a novel reproductive health education program for adolescent males with sickle cell disease
Charis J. Stanek,Susan E. Creary,Sophia M. Liles,Zachary A. Colton,Joseph R. Stanek,Gwendolyn P. Quinn,Toyetta Barnard-Kirk,Mary Ann Abrams,Leena Nahata
View Articletitled, FUTURES: efficacy and acceptability of a novel reproductive health education program for adolescent males with sickle cell disease
Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90
Clinical Trials & Observations
Angela M. Feraco,Yiwang Zhou,Ying Zheng,Lianna J. Marks,Alison Friedmann,Howard J. Weinstein,Michael P. Link,Jamie E. Flerlage
View Articletitled, Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90
Contraception, pregnancy, and STI counseling and care among transitioning young adults with sickle cell disease
Divya Shankar,Charis J. Stanek,Suzy Bangudi,Sophia M. Liles,Zachary A. Colton,Laura C. Hart,Robert M. Cronin,Susan E. Creary,Leena Nahata
View Articletitled, Contraception, pregnancy, and STI counseling and care among transitioning young adults with sickle cell disease
Age-specific impact of type I interferons on cerebral thrombosis and inflammation
Frederik Denorme,Izabella Andrianova,Mark J. Cody,Yasuhiro Kosaka,Robert A. Campbell
View Articletitled, Age-specific impact of type I interferons on cerebral thrombosis and inflammation
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy
Janneke W. de Boer,Elise R. A. Pennings,Ankie Kleinjan,Jaap A. van Doesum,Anne M. Spanjaart,Pim G. N. J. Mutsaers,Margot Jak,Marjolein W. M. van der Poel,Maria T. Kuipers,Judit A. Adam,Arjan Diepstra,Lianne Koens,Suzanne van Dorp,Joost S. P. Vermaat,Anne G. H. Niezink,Marie José Kersten,Tom van Meerten
View Articletitled, Inflammatory reactions mimic residual or recurrent lymphoma on [<sup>18</sup>F]FDG-PET/CT after CD19-directed CAR T-cell therapy
Single-agent rituximab is an effective salvage therapy in pretreated patients with hairy cell leukemia
Clinical Trials & Observations
Alessandro Broccoli,Lisa Argnani,Laura Nanni,Vittorio Stefoni,Cinzia Pellegrini,Beatrice Casadei,Gabriele Gugliotta,Matteo Carella,Paolo Elia Coppola,Gianmarco Bagnato,Pier Luigi Zinzani
View Articletitled, Single-agent rituximab is an effective salvage therapy in pretreated patients with hairy cell leukemia
Supplemental data
Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
Clinical Trials & Observations
Nathanael R. Fillmore,Jennifer La,Julie Tsu-Yu Wu,June K. Corrigan,Westyn Branch-Elliman,Paul Monach,Mary T. Brophy,Nhan V. Do,Nikhil C. Munshi
View Articletitled, Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma
Clinical Trials & Observations
Paolo Strati,Andrew Jallouk,Qing Deng,Xubin Li,Lei Feng,Ryan Sun,Sherry Adkins,Swapna Johncy,Taylor Cain,Raphael E. Steiner,Sairah Ahmed,Dai Chihara,Luis E. Fayad,Swaminathan P. Iyer,Sandra Horowitz,Loretta J. Nastoupil,Ranjit Nair,Ahmed Hassan,Taher E. Daoud,Misha Hawkins,Maria A. Rodriguez,Elizabeth J. Shpall,Jeremy L. Ramdial,Partow Kebriaei,David S. Hong,Jason R. Westin,Sattva S. Neelapu,Michael R. Green
View Articletitled, A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma
Supplemental data
ICANS prophylaxis: potentially transformative but elusive
Clinical Trials & Observations
Mark R. Dowling,Cameron J. Turtle
View Articletitled, ICANS prophylaxis: potentially transformative but elusive

COMMENTARIES

Commentary on the 2023 ASH guidelines for thrombophilia testing in venous thromboembolism
Manu Juneja,Jeff Szer
View Articletitled, Commentary on the 2023 ASH guidelines for thrombophilia testing in venous thromboembolism
Hematology referral madness syndrome
Benjamin Djulbegovic,Charles S. Greenberg
View Articletitled, Hematology referral madness syndrome
ASH Clinical Practice Guidelines: strategies to stay up-to-date
Matthew C. Cheung,Rob Kunkle,Rob Plovnick,Richard Lottenberg,Suely M. Rezende,Roy Silverstein,Menaka Pai,Matthew Seftel,Adam Cuker
View Articletitled, ASH Clinical Practice Guidelines: strategies to stay up-to-date

RESPONSE

Should we move to a genomic classification of neutrophilic myeloid neoplasms?
Clinical Trials & Observations
Gonzalo Carreño-Tarragona,Alberto Álvarez-Larrán,Juan Carlos Hernández-Boluda,Rosa Ayala,Nicholas C. P. Cross
View Articletitled, Should we move to a genomic classification of neutrophilic myeloid neoplasms?

ERRATUM

Gill S, Vides V, Frey NV, et al. Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia. Blood Adv. 2022;6(21):5774-5785.
View Articletitled, Gill S, Vides V, Frey NV, et al. Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia. <em>Blood Adv</em>. 2022;6(21):5774-5785.
All Issues

Advertisement

Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy
Phillips NS, Mulrooney DA, Williams AM, et al. Neurocognitive impairment associated with chronic morbidity in long-term survivors of Hodgkin Lymphoma. Blood Adv. 2023;7(23):7270-7278.
Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia
Race and ethnicity reporting and representation in hemophilia clinical trials

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement